In Figure 2, impairment of mitochondrial β-oxidation due to increased PPAR-γ, FABP, activator protein-2 (ap2) and suppressed PPARα and CPT-1α highly contributes to the pathogenetic mechanism of hepatic steatosis [46]. The gene discussed is TFAP2A; the disease is fatty liver disease.